| Line Item | 2026-03-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $846.0M | — | +30.4% |
| Cost of Revenue | $664.8M | — | +28.4% |
| Gross Profit | $181.2M | — | +38.3% |
| R&D Expense | $7.8M | — | -3.2% |
| SG&A Expense | $68.7M | — | +57.0% |
| Operating Income | $72.4M | — | +44.1% |
| Pre-tax Income | $58.5M | — | +42.8% |
| Income Tax | $8.5M | — | -3.1% |
| Net Income | $50.0M | — | +55.3% |
| EPS (Basic) | $0.48 | — | +50.0% |
| EPS (Diluted) | $0.47 | — | +51.6% |
| Line Item | 2026-03-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $410.0M | -18.2% | -0.3% |
| Accounts Receivable | $618.1M | +9.6% | +24.6% |
| Inventory | $280.2M | +12.1% | +13.5% |
| Current Assets | $1.91B | +3.1% | +20.8% |
| Total Assets | $3.98B | +3.7% | +15.2% |
| Current Liabilities | $1.02B |
| Line Item | 2026-03-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $21.7M | — | +304.1% |
| Capital Expenditures | $106.8M | — | +68.7% |
| Investing Cash Flow | -$106.8M | — | -68.9% |
| Financing Cash Flow | -$6.2M | — | +67.1% |
| Free Cash Flow | -$85.1M | — | -15.0% |
| +32.8% |
| Long-term Debt | $915.7M | -0.0% | -0.2% |
| Stockholders' Equity | $1.84B | +4.3% | +15.8% |